Navigation Links
CNS Response, Inc. Enters Agreement to Introduce rEEG(R) Platform to Managed Behavioral Health Organization
Date:3/31/2008

derations."

About CNS Response

CNS Response is a life-sciences data company focused on the commercialization of the first patented commercial system that guides psychiatrists and other physicians to determine proper treatments for patients with behavioral (mental or addictive) disorders. This technology allows CNS Response to create and provide simple reports ("rEEG(R) Reports") that specifically guide physicians to treatment strategies based on the patient's own physiology.

rEEG(R) utilizes traditional electroencephalography (EEG) in conjunction with a normative database and a proprietary clinical (symptomatic) database to identify the following: (1) medication classes most likely to be needed; and (2) medications within these classes with the most probable treatment potential for each patient. Reports are provided to physicians in a relationship analogous to that of a reference laboratory. Prospective, retrospective and field studies of treatment-resistant patients have reported treatment success of 70% or greater in managed care, outpatient psychiatric and residential substance abuse clinical settings.

In addition to providing analytical support to physicians, CNS Response is also an aide to pharmaceutical developers, who can use rEEG to (1) stratify study populations to improve the success of FDA clinical trials; (2) provide insight on effective therapeutic dosing of investigational drugs; (3) identify additional indications for psychiatric medications; (4) provide insight into effective drug combinations; and (5) discover opportunities for decision analytics and support. In addition to these applications, CNS Response continues to investigate the use of rEEG analysis for development of proprietary pharmaceutical opportunities.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995

Except for the historical information contained herein, the matters discussed are forward-looking statements made p
'/>"/>

SOURCE CNS Response, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Bacterial toxin closes gate on immune response, Penn researchers discover
2. CNS Response, Inc. Names Henry T. Harbin, MD to Board of Directors
3. CNS Response, Inc. Modifies rEEG(SM) Trial Protocol for Treatment-Resistant Depression Study
4. CNS Response, Inc. Appoints George C. Carpenter IV to Position of President
5. ISBT 128 Labeling Implementation Date Looms for Blood Centers
6. MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital-Dayton
7. Haemonetics(R) Software Solutions to Launch Application for Workflow Optimization in Blood Collection Centers
8. Companies Not Fully Tapping Potential of Onsite Health Centers
9. Independence Blue Cross Announces Blue Distinction Centers for Complex and Rare Cancers(SM) in Philadelphia
10. Highmark Blue Shield and National Association Name Area Hospitals as Blue Distinction Centers for Complex and Rare Cancers
11. Hospital Caregivers Unveil Billboards Calling for Improved Patient Care, Quality Jobs at Community Medical Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Introducing 3D Digital Technologies to ... recognized leader in Digital Dentistry. Acute precision in ... dental replicas, leaving no room for error during ... professionals are able to significantly reduce “chair time” ... remarkable quality while reducing labor and material costs ...
(Date:3/3/2015)... March 03, 2015 Birth Boot ... today they now have over 130 certified instructors in ... in Germany. In addition, the company recently launched a ... childbirth educator certification program . Birth Boot Camp ... her birth partner. The practical information can be used ...
(Date:3/3/2015)... March 03, 2015 The FSH ... science of the little-known and incurable disease, facioscapulohumeral muscular ... #CureFSHD campaign . The purpose of the campaign is ... of the most common forms of muscular dystrophies. ... campaign, today the FSH Society will begin sharing impactful ...
(Date:3/3/2015)... Jack Coats, Chief Executive Officer of ... Breukelman has been named to the company’s Board of ... first fully integrated version of its Multiparametric Strain Analysis ... three-dimensional motion of the heart that is acquired from ... 15,300 points to the motion of a normal heart ...
(Date:3/3/2015)... March 03, 2015 Raritan Bay Medical ... of Health,” an interactive photo contest held at the ... 8, 2015. To raise awareness for health and wellness ... to share their best health and wellness tips. , ... Bay Medical Center’s website and Facebook page where Facebook ...
Breaking Medicine News(10 mins):Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 2Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 3Health News:Expectant Couples Worldwide Can Now Receive Training and Education in Natural Childbirth and Breastfeeding from Birth Boot Camp 2Health News:Share to be Aware: FSH Society Launches #CureFSHD Campaign 2Health News:Share to be Aware: FSH Society Launches #CureFSHD Campaign 3Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 2Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 3Health News:Raritan Bay Medical Center Announces Winners of “Picture of Health” Photo Contest 2
... Hodgkins Lymphoma should be especially vigilant about cancer ... Forest University Baptist Medical Center and colleagues. , ... Society of Clinical Oncology in Chicago today, Sharon ... study of 1,927 Hodgkins survivors found that treatments ...
... prolonged progression-free survival, study finds , , SATURDAY, May ... to chemotherapy lengthened progression-free survival in women with ... studies have found that adding Avastin (bevacizumab) to ... advanced breast cancer actually doubled progression-free survival. , ...
... 2008) -- Leading oncologists and cancer researchers at ... basic and clinical research findings at the 44th ... in Chicago, May 30 to June 3. , ... be made by NewYork-Presbyterian/Weill Cornell physician-scientists include the ...
... May 30 Hero Nutritionals,introduced Slice of Life, a ... Products Expo West in March 2008. Included in the ... CoQ10 is found in every cell in,the body, its ... for ,found everywhere, low levels of the vital nutrient ...
... of Asthmatics Applauds FDA Public Health ... Patients Need to Know, FAIRFAX, Va., May 30 ... not know that at the end of this,year, their ... using chlorofluorocarbon (CFC) albuterol metered-dose inhalers (MDIs),to switch to ...
... ... year-over-year to $87.5 ... beds served increased 8.5% year-over-year to 65,700 at March 31, 2008 - First quarter ... - Stock symbol changed to CHRX from PMQC, LONG BEACH, N.Y., May ...
Cached Medicine News:Health News:Survivors of childhood Hodgkin's lymphoma at higher risk of future health problems 2Health News:Avastin Added to Chemo Helps Women With Advanced Cancer 2Health News:Avastin Added to Chemo Helps Women With Advanced Cancer 3Health News:NYP/Weill Cornell physician-scientists present latest cancer findings at ASCO meeting 2Health News:NYP/Weill Cornell physician-scientists present latest cancer findings at ASCO meeting 3Health News:NYP/Weill Cornell physician-scientists present latest cancer findings at ASCO meeting 4Health News:Get the Facts on the Albuterol Inhaler Transition 2Health News:Get the Facts on the Albuterol Inhaler Transition 3Health News:Chem Rx Corporation Reports First Quarter 2008 Financial Results 2Health News:Chem Rx Corporation Reports First Quarter 2008 Financial Results 3Health News:Chem Rx Corporation Reports First Quarter 2008 Financial Results 4Health News:Chem Rx Corporation Reports First Quarter 2008 Financial Results 5Health News:Chem Rx Corporation Reports First Quarter 2008 Financial Results 6Health News:Chem Rx Corporation Reports First Quarter 2008 Financial Results 7Health News:Chem Rx Corporation Reports First Quarter 2008 Financial Results 8Health News:Chem Rx Corporation Reports First Quarter 2008 Financial Results 9
(Date:3/3/2015)... -- - CPhI and P-MEC China 2015 ... Shanghai, China - The 15th ... held at Shanghai New International Expo Center, on 24th June, ... Worldwide and was introduced to China in 2001. It has ... companies and global pharmaceutical industry over the past 15 years. ...
(Date:3/3/2015)... , Mar. 03, 2015 Research and Markets ... Jain PharmaBiotech,s new report "Cardiovascular Drug Delivery - ... , Drug delivery to the cardiovascular system ... the anatomy and physiology of the vascular system; it ... body. Drugs can be introduced into the vascular system ...
(Date:3/3/2015)... , March 3, 2015  HeartIT is pleased ... first Cardiac Magnetic Resonance Solution in the market ... a standard web browser. Precession™ combines zero footprint ... unmatched in the industry. This provides CMR professionals ... the critical functions of a successful CMR program. ...
Breaking Medicine Technology:15th Anniversary, Be Part of Chinese Pharma Dream 215th Anniversary, Be Part of Chinese Pharma Dream 3Global Cardiovascular Drug Delivery Technologies, Markets and Companies 2014-2024 2Global Cardiovascular Drug Delivery Technologies, Markets and Companies 2014-2024 3Precession Advances Medical Imaging by Delivering a Complete Cardiac Magnetic Resonance Platform in a Web Browser 2
... (1.5x) Gonio lens will enable visualization of ... mirror lens is the industry preferred standard ... features : , Crispest, clearest imaging ... unattainable with Gonio lenses., 4 equally angled ...
... alternative to bulky biometry devices that have ... AP2000 is the world's only battery-operated, fully ... the market today. Each unit weighs a ... perform multiple functions, namely: auto data capture, ...
... The PiGalileo™ ... System from PLUS ... Surgery technology and ... technologies to assist ...
... a low TLR (<1%) and stroke rate ... and long-term durability., , , High Radial ... carotid artery, increasing lumen diameter with chronic ... Minimal stent shortening, low profile design, Cordis ...
Medicine Products: